The Zika virus, an RNA arbovirus, is known to trigger Guillain-Barré syndrome (GBS). However, to establish that the Zika virus is indeed the causative agent, its presence must be confirmed - preferably via direct PCR. Detection of anti-Zika IgM antibodies should not be used for this purpose, as they can persist. Confirming Zika as the trigger for GBS also requires ruling out all other potential causes of the syndrome. Furthermore, all comorbidities and concomitant medications must be documented and included in the analysis. Finally, it is essential to refer GBS patients, regardless of the underlying cause, to a specialized department as soon as typical clinical symptoms appear.
No takes yet. Share an insight, caveat, or question.
Scorza et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: